Connecticut Children's Medical Center; 5E Clinical Trials Unit

Hartford, Connecticut 06106

0 studies enrolling now · 2 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed